We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+7.87%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$15.9B
AUM Growth
+$1.24B
(+8.5%)
Cap. Flow
+$523M
Cap. Flow
% of AUM
3.3%
Top 10 Holdings %
Top 10 Hldgs %
35.05%
Holding
1,298
New
139
Increased
794
Reduced
319
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$228M |
| 2 |
KraneShares CSI China Internet ETF
KWEB
|
+$41.5M |
| 3 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$35.7M |
| 4 |
Intel
INTC
|
+$34.7M |
| 5 |
Blackstone
BX
|
+$34.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
A10 Networks
ATEN
|
+$258M |
| 2 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$255M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$197M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$83.7M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.02% |
| 2 | Financials | 19.16% |
| 3 | Energy | 5.34% |
| 4 | Healthcare | 4.01% |
| 5 | Industrials | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Caterpillar
CAT
$373B
| $2.49M | 0.02% |
11,447
+2,027
| +22% | +$468K |
|
602
Agios Pharmaceuticals
AGIO
$1.95B
| $2.49M | 0.02% |
45,179
-19,400
| -30% | -$1.08M |
|
603
Regenxbio
RGNX
$648M
| $2.49M | 0.02% |
64,090
-17,619
| -22% | -$630K |
|
604
Coherus Oncology
CHRS
$227M
| $2.49M | 0.02% |
179,895
-25,151
| -12% | -$356K |
|
|
AVYA
605
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.49M | 0.02% |
92,490
-17,488
| -16% | -$492K |
|
606
BridgeBio Pharma
BBIO
$16.1B
| $2.49M | 0.02% |
40,803
-6,147
| -13% | -$351K |
|
607
Avis
CAR
$5.37B
| $2.49M | 0.02% |
31,919
+17,468
| +121% | +$1.45M |
|
608
Eagle Materials
EXP
$6.3B
| $2.48M | 0.02% |
17,445
+2,406
| +16% | +$346K |
|
609
Zentalis Pharmaceuticals
ZNTL
$350M
| $2.47M | 0.02% |
46,448
-19,078
| -29% | -$1.02M |
|
610
Insmed
INSM
$22B
| $2.47M | 0.02% |
86,779
+1,599
| +2% | +$47.5K |
|
611
BioCryst Pharmaceuticals
BCRX
$2.35B
| $2.47M | 0.02% |
156,107
-107,477
| -41% | -$1.46M |
|
|
AZEK
612
DELISTED
The AZEK Co
AZEK
| $2.46M | 0.02% |
57,960
+13,019
| +29% | +$583K |
|
613
Gen Digital
GEN
$16.3B
| $2.46M | 0.02% |
90,349
+6,355
| +8% | +$158K |
|
614
Atara Biotherapeutics
ATRA
$73.6M
| $2.46M | 0.02% |
6,324
-1,561
| -20% | -$557K |
|
615
Cytokinetics
CYTK
$10.9B
| $2.45M | 0.02% |
123,981
-22,020
| -15% | -$517K |
|
|
XLRN
616
DELISTED
Acceleron Pharma
XLRN
| $2.45M | 0.02% |
19,547
-4,676
| -19% | -$590K |
|
|
MRTX
617
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.45M | 0.02% |
15,161
-2,374
| -14% | -$381K |
|
618
Ultragenyx Pharmaceutical
RARE
$2.56B
| $2.44M | 0.02% |
25,646
-599
| -2% | -$62.4K |
|
619
Arrowhead Research
ARWR
$12.3B
| $2.44M | 0.02% |
29,408
-16,384
| -36% | -$1.22M |
|
620
Kura Oncology
KURA
$826M
| $2.43M | 0.02% |
116,348
+3,406
| +3% | +$84.6K |
|
621
Revolution Medicines
RVMD
$40.9B
| $2.42M | 0.02% |
76,114
+6,074
| +9% | +$212K |
|
|
ICPT
622
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.42M | 0.02% |
120,991
-37,601
| -24% | -$745K |
|
|
BHVN
623
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.41M | 0.02% |
24,837
-16,031
| -39% | -$1.3M |
|
624
Bath & Body Works
BBWI
$4.02B
| $2.4M | 0.02% |
41,146
+7,531
| +22% | +$407K |
|
625
Target
TGT
$65.6B
| $2.4M | 0.02% |
9,912
+1,459
| +17% | +$319K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Rafferty Asset Management held 1,298 positions worth $15.9B, up 8.5% from $14.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management deployed $523M of net new capital in Q2 2021, opening 139 new positions and adding to 794 existing holdings. Its largest new stake was Blackstone: 386,473 shares worth $37.5M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $197M trimmed.
- Rafferty Asset Management's largest Q2 2021 buy was Blackstone: 386,473 shares worth $37.5M.
- Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $228M increase.
- Rafferty Asset Management's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $197M.
- Rafferty Asset Management fully exited A10 Networks in Q2 2021, selling an estimated $258M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $15.9B portfolio in Q2 2021.
- Rafferty Asset Management opened 139 new positions and closed 45 in Q2 2021.
- Rafferty Asset Management's portfolio value rose 8.5% quarter-over-quarter to $15.9B.
Based on Rafferty Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.